Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...

In particular, Keytruda for cancer represents a key blockbuster ... advertising on our websites and newsletters. How we use your information depends on the product and service that you use and ...

Merck & Co.'s heavy reliance on its cancer drug Keytruda, which accounts for nearly half of the company's revenue, is raising investor concerns as the drug's patent expiration approaches in 2028 ...

The FBI on Tuesday released “seeking information posters” for two Iranian intelligence officers who they believe were involved in the disappearance of former FBI agent Robert Levinson.

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.

The FBI Washington Field Office today released seeking information posters featuring two senior Iranian intelligence officers, Ahmad Khazai, left, and Mohammad Baseri, who are believed to have ...

The FBI on Tuesday released “seeking information posters” for two Iranian intelligence officers who they believe were involved in the disappearance of former FBI agent Robert Levinson. The US has ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial.